title: Indications for the use of Gd-DTPA in MRI of the central nervous system. Experiences in patients with cerebral and spinal diseases.
abstract: A total of 209 intracranial and spinal diseases were evaluated before and after administration of the paramagnetic contrast agent Gd-DTPA. The results justify the use of Gd-DTPA in intracranial and spinal tumors for better visualization of location and extent of a lesion and for better tissue differentiation. In inflammatory diseases Gd-DTPA allows the differentiation between active and chronic lesions.
authors.affiliation: Department of Radiology, University of Munich, Klinikum, Grosshadern, FRG.
authors.forename: W M
authors.initials: WM
authors.lastname: Bauer
authors.forename: G
authors.initials: G
authors.lastname: Fenzl
authors.forename: T
authors.initials: T
authors.lastname: Vogl
authors.forename: U
authors.initials: U
authors.lastname: Fink
authors.forename: J
authors.initials: J
authors.lastname: Lissner
mesh_terms: D001932:Brain Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D009942:Organometallic Compounds; D004369:Pentetic Acid; D013125:Spinal Neoplasms / Q000175:diagnosis*
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA